DarioHealth (NASDAQ:DRIO – Get Free Report) is anticipated to release its earnings data before the market opens on Monday, March 10th. Analysts expect DarioHealth to post earnings of ($0.16) per share and revenue of $7.39 million for the quarter.
DarioHealth Stock Performance
NASDAQ:DRIO opened at $0.67 on Thursday. The company has a fifty day simple moving average of $0.73 and a two-hundred day simple moving average of $0.82. The company has a market cap of $22.90 million, a price-to-earnings ratio of -0.71 and a beta of 1.39. The company has a quick ratio of 1.32, a current ratio of 1.57 and a debt-to-equity ratio of 0.35. DarioHealth has a 52 week low of $0.56 and a 52 week high of $1.93.
Wall Street Analysts Forecast Growth
Separately, TD Cowen downgraded shares of DarioHealth from a “buy” rating to a “hold” rating and lowered their target price for the stock from $2.00 to $1.00 in a research note on Wednesday, January 29th.
DarioHealth Company Profile
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Featured Articles
- Five stocks we like better than DarioHealth
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- There Are Different Types of Stock To Invest In
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Insider Trades May Not Tell You What You Think
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.
